Goldman Sachs Portfolio holdings
Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$4.27B |
| 2 |
Zimmer Biomet
ZBH
|
+$3.42B |
| 3 |
TransUnion
TRU
|
+$1.8B |
| 4 |
Qualcomm
QCOM
|
+$587M |
| 5 |
Alibaba
BABA
|
+$434M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$1.06B |
| 2 |
Pfizer
PFE
|
+$895M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$631M |
| 4 |
RTX Corp
RTX
|
+$546M |
| 5 |
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
|
+$516M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 8.41% |
| 2 | Healthcare | 8.04% |
| 3 | Technology | 7.66% |
| 4 | Energy | 6.94% |
| 5 | Consumer Discretionary | 6.37% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4651
CALL
Textron
TXT
$14.7B
| $817K | ﹤0.01% |
18,300
-3,200
| -15% | -$145K |
|
|
WWE
4652
CALL
DELISTED
World Wrestling Entertainment
WWE
| $817K | ﹤0.01% |
49,500
-61,700
| -55% | -$895K |
|
4653
Build-A-Bear
BBW
$425M
| $815K | ﹤0.01% |
50,941
+22,859
| +81% | +$405K |
|
4654
New Oriental
EDU
$9.37B
| $815K | ﹤0.01% |
33,231
-566,656
| -94% | -$14M |
|
|
VXZ
4655
DELISTED
iPath S&P 500 VIX Mid-Term Futures ETN due 1/30/2019
VXZ
| $815K | ﹤0.01% |
18,225
+977
| +6% | +$45.1K |
|
4656
PUT
KeyCorp
KEY
$24.2B
| $811K | ﹤0.01% |
54,000
+3,400
| +7% | +$50.1K |
|
|
ETV
4657
Eaton Vance Tax-Managed Buy-Write Opportunities Fund
ETV
$1.71B
| $809K | ﹤0.01% |
54,562
+11,531
| +27% | +$174K |
|
4658
HealthEquity
HQY
$8.41B
| $809K | ﹤0.01% |
25,247
-8,803
| -26% | -$236K |
|
4659
Par Pacific Holdings
PARR
$4.31B
| $808K | ﹤0.01% |
43,159
+10,516
| +32% | +$243K |
|
4660
Sturm, Ruger & Co
RGR
$594M
| $807K | ﹤0.01% |
14,062
-66,672
| -83% | -$3.63M |
|
4661
CALL
Spectrum Brands
SPB
$2.04B
| $806K | ﹤0.01% |
7,900
+2,600
| +49% | +$244K |
|
4662
CALL
PTC Therapeutics
PTCT
$5.68B
| $804K | ﹤0.01% |
16,700
-47,500
| -74% | -$2.77M |
|
4663
PUT
Banco Santander
SAN
$201B
| $804K | ﹤0.01% |
120,849
+13,486
| +13% | +$94K |
|
|
JUNO
4664
DELISTED
Juno Therapeutics, Inc.
JUNO
| $804K | ﹤0.01% |
15,080
-1,981
| -12% | -$105K |
|
|
SALE
4665
DELISTED
RetailMeNot, Inc. Series 1
SALE
| $803K | ﹤0.01% |
45,037
-10,937
| -20% | -$210K |
|
4666
CALL
Mohawk Industries
MHK
$7.5B
| $802K | ﹤0.01% |
4,200
-6,100
| -59% | -$1.13M |
|
|
CALL
4667
DELISTED
magicJack VocalTec Ltd
CALL
| $802K | ﹤0.01% |
107,951
+63,708
| +144% | +$475K |
|
4668
Santander
BSBR
$42.5B
| $799K | ﹤0.01% |
153,460
-276,657
| -64% | -$1.4M |
|
4669
PUT
O-I Glass
OI
$1.1B
| $798K | ﹤0.01% |
34,800
+16,800
| +93% | +$409K |
|
|
QLTY
4670
DELISTED
QUALITY DISTR INC FLA
QLTY
| $798K | ﹤0.01% |
+51,609
| New | +$697K |
|
4671
Vanguard Extended Market ETF
VXF
$30.3B
| $796K | ﹤0.01% |
8,655
+49
| +0.6% | +$4.55K |
|
|
ESND
4672
DELISTED
Essendant Inc.
ESND
| $796K | ﹤0.01% |
20,279
+7,870
| +63% | +$318K |
|
|
AMED
4673
CALL
DELISTED
Amedisys
AMED
| $795K | ﹤0.01% |
+20,000
| New | +$623K |
|
4674
PUT
Dover
DOV
$27.6B
| $793K | ﹤0.01% |
13,989
-5,200
| -27% | -$310K |
|
|
AREX
4675
DELISTED
Approach Resources Inc.
AREX
| $793K | ﹤0.01% |
115,746
-256,541
| -69% | -$1.94M |
|
Similar funds
Goldman Sachs's Q2 2015 Portfolio in Review
As of Q2 2015, Goldman Sachs held 7,731 positions worth $323B, up 3.7% from $311B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Goldman Sachs deployed $13.1B of net new capital in Q2 2015, opening 673 new positions and adding to 3,224 existing holdings. Its largest new stake was TransUnion: 72,355,340 shares worth $1.82B.
By sector, the portfolio is most concentrated in Financials at 8.4% of assets, up from 8% a quarter earlier, followed by Healthcare and Technology.
On the sell side, the largest reduction was Gilead Sciences, an estimated $1.06B trimmed.
- Goldman Sachs's largest Q2 2015 buy was TransUnion: 72,355,340 shares worth $1.82B.
- Goldman Sachs added most to State Street SPDR S&P 500 ETF Trust in Q2 2015, an estimated $4.27B increase.
- Goldman Sachs's biggest Q2 2015 reduction was Gilead Sciences, cutting an estimated $1.06B.
- Goldman Sachs fully exited LORILLARD INC COM STK in Q2 2015, selling an estimated $386M.
- Goldman Sachs's ten largest holdings make up 14% of its $323B portfolio in Q2 2015.
- Goldman Sachs opened 673 new positions and closed 497 in Q2 2015.
- Goldman Sachs's portfolio value rose 3.7% quarter-over-quarter to $323B.
Based on Goldman Sachs's 13F filing for Q2 2015, filed 14 Aug 2015.